Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs - Test2 - elhamkhani - TriplyDB

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

http://www.wikidata.org/entity/Q29042551

about

Perfringolysin O Theta Toxin as a Tool to Monitor the Distribution and Inhomogeneity of Cholesterol in Cellular Membranes Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish The impact of chronic stress on the rat brain lipidome The dynamics of the stress neuromatrix Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine Amitriptyline Usage Exacerbates the Immune Suppression Following Burn Injury β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections Of mice and men: modelling post-stroke depression experimentally.Antidepressants and the adolescent brain.Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.Lipids under stress--a lipidomic approach for the study of mood disorders.Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory.Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy.Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane.Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.Crystal structure of mammalian acid sphingomyelinase Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis.The emerging role of acid sphingomyelinase in autophagy.Role of sphingomyelinases in neurological disorders.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Amplification of a FRET Probe by Lipid-Water Partition for the Detection of Acid Sphingomyelinase in Live Cells.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Direct inhibition of retinoic acid catabolism by fluoxetine.Regulation of hematogenous tumor metastasis by acid sphingomyelinase.Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.Sphingolipids: membrane microdomains in brain development, function and neurological diseases.A sphingolipid mechanism for behavioral extinction.Editorial: Membrane domains as new drug targets.Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination Serotonin Depletion Does not Modify the Short-Term Brain Hypometabolism and Hippocampal Neurodegeneration Induced by the Lithium-Pilocarpine Model of Status Epilepticus in Rats.Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives Mood disorders: room for improvement.Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.Plasma sphingolipids and depressive symptoms in coronary artery disease.Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis.Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.

P2860

237b6535191de2f9423039f7933e26de4f827529

P248

Q26752559-B218D9F9-6679-46FB-AF29-EAA0A50496FB Q26852322-166EEC22-DDB1-4E96-897B-DEBC8644B756 Q26866012-2C67D9E4-6465-490B-8CC9-5DFD5F394E76 Q27310913-562653D5-2AE3-4997-93C3-771D399B9D22 Q27319840-A628C23E-0F66-4A8C-A32C-0517D3B26D0D Q28076408-AEA06508-70A2-4332-9AB2-B322DA210F17 Q28270227-B2063A2F-9744-4B37-869C-5588C12FABD3 Q30370188-4CEB1F16-9F4B-44E2-ADF4-9041735E3006 Q33811046-B20BF7A9-287D-4E5A-8442-5419B26E24DD Q34407158-26E3EA45-C166-4DAD-B34D-9A8C83C3F355 Q34465941-6EF2E914-E226-42C5-AED3-8305B07CE0EC Q35149929-F098E4E1-AA4B-47DB-A62D-585ABD3F83D1 Q35795291-730C04E9-CACF-49C6-9531-BA7C67D14605 Q36123988-A0920123-B877-49A7-8B07-178500E5776D Q36363960-0FADDCE5-BCB1-49A5-B0BC-60D4F3FA5158 Q36480870-85A871A8-9E72-4A1E-A8F0-AD3E5F1BE2B1 Q36648936-E41C79D5-D44D-4B3E-A198-6C27873194F9 Q37127903-97FCE232-7DBA-4B7E-9928-9CC6775832B3 Q37389500-23BB5A9E-3325-4145-8B22-D0EB9EA9B7D8 Q37666339-E0D5B02D-F266-4FFE-9C15-D0C1FF662477 Q38349925-8D830F43-D303-4070-AE99-B82AFE4BDA80 Q38560939-AAE1344F-939B-4087-A915-D6CEEA742565 Q38607507-41B23FA5-4648-4CED-8433-D95EBC6270C4 Q38762263-E36F4DB8-9590-4AA3-96C1-216EA4B96598 Q38833111-5D07BC42-675C-4FAB-BCAB-FF541677F0D1 Q38874017-7F5D567B-6911-4818-8287-BCE94A49CAB8 Q38889875-63C95FEF-4D96-49CE-99A5-4C09328D88DB Q39340736-74738D41-A953-411E-8F10-67BB5C354966 Q39342245-5AFB59B1-33D0-4472-8745-D7417E44DB34 Q40084446-786C33D3-3836-485D-A01F-73CC88021E67 Q41513306-2B5D1EE0-EF09-4601-90F2-DDB0637C0788 Q42221029-7DE96CED-57F5-45F8-B5A1-2A60ED00A5A7 Q42480180-EDBD247F-2D68-4E6F-8115-46962C3694A5 Q42621396-447A98C4-9061-41B8-B73F-EFC6571898FB Q45391079-2D675D10-0A11-4923-8DE7-7AF609086CC0 Q45763186-E9187726-5490-46B6-A04D-7262D9CCC831 Q46248790-216C924B-7A55-44B6-B1D0-9C1B79ECBB55 Q46426783-D650A546-E056-4BDB-871D-2BC457675E39 Q47241393-E1EABB3D-A22D-43AE-8DB2-13D41EFCA5DE Q47586716-AE82EE03-74ED-488B-B0CE-D573A64F57D6

P2860

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

http://www.wikidata.org/entity/Q29042551

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@ast

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@en

type

label

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@ast

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@en

prefLabel

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@ast

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@en

P1433

Q29042551-F5F9A5B4-B14E-4343-8109-579597262608

P1476

Q29042551-026E08F5-F457-45DE-8EAC-17E92C3CD844

P2093

Q29042551-0EFDCA43-96A0-44DF-936B-78A75FB32BE0

Q29042551-46DE5B08-2544-44B6-A3B9-5FCF672720F9

Q29042551-53FE4064-76C9-433F-B52E-D6E62FDD2522

Q29042551-594B3A14-559C-4CB2-8D1D-66E284D30B55

Q29042551-8367F541-4B6A-4817-8F06-C404C7DAA416

Q29042551-87799855-6ADE-45A6-BFC9-64E5BC4466D7

Q29042551-9315D186-5C99-4DF8-A271-B05A87378487

Q29042551-B09DF575-8CDA-435F-BECE-582B951FC615

Q29042551-C8B86F00-770B-45FA-866E-4E0C3DAF6D76

Q29042551-D741424F-5FBE-4F39-AD19-12F97F06FC8E

P2860

Q29042551-05BC6B45-93A5-432D-B697-C845ABF66E11

Q29042551-0B771F75-62E7-41E9-BD79-2F9D7EE26BBB

Q29042551-18A9BE2C-3A17-4EAF-B74D-44B709F5BED2

Q29042551-1968D14B-3A50-4598-A739-1C758BEDCB78

Q29042551-286C2F2B-A278-47F8-9156-6FF1B20A02FD

Q29042551-2FF46770-9ED5-40D8-91F7-791886106C7D

Q29042551-495EBFAD-DAF2-4472-817D-F8E0561FDE82

Q29042551-5028CB11-8BF1-49AB-B2FB-5F64632882E3

Q29042551-63022D88-3E03-414F-9CBD-1BE0E92A3F57

Q29042551-79DD33BC-C107-44C0-88EB-5B8325A2ECE6

P2888

Q29042551-BCA45564-D020-4658-A458-D7FAEEFE32BB

P304

Q29042551-DF27582A-6ED2-488C-8C1C-7AA1C668D887

P31

Q29042551-11D6B5E6-A654-4BC2-9727-A5960EF0D6D5

P3181

Q29042551-7BBE63DB-2962-4086-9227-BA3BF5CD259B

P356

Q29042551-72DA98ED-7AB8-496D-AD57-83669080AB71

P407

Q29042551-D34A5282-9833-46E7-9D6C-5E0CF467BD64

P433

Q29042551-FEB6C4A8-E34F-496F-AFBB-00BA4B43CABC

P478

Q29042551-B92F7E1B-ACF0-40B7-BF8A-369D14A0EAB3

P50

Q29042551-020C5937-EBD9-4940-900B-9BC57A4C7F9D

Q29042551-1074C83C-545A-413D-AD8E-ED9CFE55039D

Q29042551-4B021A30-DE81-4CFE-B0A9-53CB9D9AD982

Q29042551-4B124EB9-5D6F-43E0-AB7B-4434A6C835D5

Q29042551-64F4EE57-D252-467B-8C12-EA3DEF83B71D

Q29042551-77775EF7-0FF5-4A87-97D4-E6E464E43A69

Q29042551-DDACD5F4-AB38-4838-9DB7-68FD9FA0E784

Q29042551-E7023BDE-19FB-4F94-BDFC-E4CFC64ABC60

Q29042551-F3948A9D-AEA8-46D3-B74F-CCAD5DE32B02

P577

Q29042551-2F94ED83-D4F3-42AB-A0FF-463D90CED76C

P5875

Q29042551-FAA16E33-F2CD-4DA8-A383-FC5443B05DBA

P6179

Q29042551-D0FC0FBE-F7E6-49CF-BA50-618A09561531

P698

Q29042551-6D1A05D0-BCBF-4525-9501-0C61036CEA75

P3181

P356

P1433

Nature Medicine

P1476

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

@en

P2093

Anja Lüth

http://www.w3.org/2001/XMLSchema#string

Carsten H Tischbirek

http://www.w3.org/2001/XMLSchema#string

Christian Alzheimer

http://www.w3.org/2001/XMLSchema#string

Christoph Böhmer

http://www.w3.org/2001/XMLSchema#string

Davide Amato

http://www.w3.org/2001/XMLSchema#string

Johannes van Brederode

http://www.w3.org/2001/XMLSchema#string

Martin Reichel

http://www.w3.org/2001/XMLSchema#string

Monica Palmada

http://www.w3.org/2001/XMLSchema#string

Philipp Tripal

http://www.w3.org/2001/XMLSchema#string

Sven Staedtler

http://www.w3.org/2001/XMLSchema#string

P2860

Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function

Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease

The molecular neurobiology of depression

Tianeptine: a novel atypical antidepressant that may provide new insights into the biomolecular basis of depression

Efficient in vivo manipulation of mouse genomic sequences at the zygote stage

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

A meta-analysis of cytokines in major depression

Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine.

High activity of acid sphingomyelinase in major depression.

Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment.

P2888

P304

934-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3666913

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM.3214

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Kornhuber

Teja W. Groemer

Christian P. Müller

Ghazaleh Tabatabai

Burkhard Kleuser

Katrin Anne Becker

P577

2013-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239073651

http://www.w3.org/2001/XMLSchema#string

P6179

1024624113

http://www.w3.org/2001/XMLSchema#string

P698

23770692

http://www.w3.org/2001/XMLSchema#string